Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

HYDROmorphone

HYDROmorphone
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Dilaudid LIQUID, ORAL 1 mg/mL      
Dilaudid SOLUTION, INJECTABLE 1 mg/mL, 2 mg/mL, 4 mg/mL, 10 mg/mL      
Exalgo TABLET, EXTENDED RELEASE, ORAL 8 mg, 12 mg, 16 mg    
Dilaudid, Hydrostat IR TABLET, ORAL 2 mg, 4 mg, 8 mg      

VIEW MORE Opioid Agonists
CLASS
280808

Comments:

Exalgo medication guide

HYDROmorphone extended release tablets medication guide


Dilaudid dose-capping at 0.5 -- 1 mg for initial orders --> DILAUDID Dose Interchange Process

Convert EXALGO to immediate release DILAUDID tablets at same total daily dose, with dose divided into 4-6 times daily. Should be around-the-clock dosing.

Pharmacist information for *HIGH* dose Dilaudid PCA

 

Reviewed: June 24, 2010 (EXALGO)


REMS (Exalgo, HYDROmorphone ER tablet): View FDA REMS Info


Last updated: Feb. 13, 2024







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.